Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

173 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Preoperative intensity-modulated radiotherapy with a simultaneous integrated boost combined with Capecitabine in locally advanced rectal cancer: short-term results of a multicentric study.
Lupattelli M, Matrone F, Gambacorta MA, Osti M, Macchia G, Palazzari E, Nicosia L, Navarria F, Chiloiro G, Valentini V, Aristei C, De Paoli A. Lupattelli M, et al. Among authors: nicosia l. Radiat Oncol. 2017 Aug 22;12(1):139. doi: 10.1186/s13014-017-0870-4. Radiat Oncol. 2017. PMID: 28830475 Free PMC article.
1.5T MR-Guided Daily Adaptive Stereotactic Body Radiotherapy for Prostate Re-Irradiation: A Preliminary Report of Toxicity and Clinical Outcomes.
Cuccia F, Rigo M, Figlia V, Giaj-Levra N, Mazzola R, Nicosia L, Ricchetti F, Trapani G, De Simone A, Gurrera D, Naccarato S, Sicignano G, Ruggieri R, Alongi F. Cuccia F, et al. Among authors: nicosia l. Front Oncol. 2022 Apr 13;12:858740. doi: 10.3389/fonc.2022.858740. eCollection 2022. Front Oncol. 2022. PMID: 35494082 Free PMC article.
Anal squamous cell carcinoma: Impact of radiochemotherapy evolution over years and an explorative analysis of MRI prediction of tumor response in a mono-institutional series of 131 patients.
Bonù ML, La Mattina S, Singh N, Toraci C, Spiazzi L, Terraneo F, Barbera F, Vitali P, Frassine F, Guerini A, Triggiani L, Tomasini D, Morelli V, Imbrescia J, Andreuccetti J, Frittoli B, Pittiani F, Grazioli L, Portolani N, Nicosia L, Albano D, Bertagna F, Magrini SM, Buglione M. Bonù ML, et al. Among authors: nicosia l. Front Oncol. 2022 Oct 24;12:973223. doi: 10.3389/fonc.2022.973223. eCollection 2022. Front Oncol. 2022. PMID: 36353538 Free PMC article.
1.5 T MR-guided and daily adapted SBRT for prostate cancer: feasibility, preliminary clinical tolerability, quality of life and patient-reported outcomes during treatment.
Alongi F, Rigo M, Figlia V, Cuccia F, Giaj-Levra N, Nicosia L, Ricchetti F, Sicignano G, De Simone A, Naccarato S, Ruggieri R, Mazzola R. Alongi F, et al. Among authors: nicosia l. Radiat Oncol. 2020 Mar 23;15(1):69. doi: 10.1186/s13014-020-01510-w. Radiat Oncol. 2020. PMID: 32248826 Free PMC article.
The use of SBRT in the management of oligometastatic gynecological cancer: report of promising results in terms of tolerability and clinical outcomes.
Cuccia F, Pastorello E, Vitale C, Nicosia L, Mazzola R, Figlia V, Giaj-Levra N, Ricchetti F, Rigo M, Attinà G, Ceccaroni M, Ruggieri R, Alongi F. Cuccia F, et al. Among authors: nicosia l. J Cancer Res Clin Oncol. 2021 Dec;147(12):3613-3618. doi: 10.1007/s00432-021-03802-4. Epub 2021 Sep 20. J Cancer Res Clin Oncol. 2021. PMID: 34545423
173 results